Germline mutations in Peruvian patients with hemophilia B: Pattern of mutation in AmerIndians is similar to the putative endogenous germline pattern

Human Mutation

Volumn 11, Issue 5, 1998, Pages 372-376

  Heit, John A ^a   Thorland, Erik C ^b   Ketterling, Rhett P ^b   Lind, Tammy J ^b   Daniels, Todd M ^a   Zapata, Renee Eyzaguirre ^c   Ordonez, Saul Mendoza ^d   Kasper, Carol K ^e   Sommer, Steve S ^b,f  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c Peruvian Inst of Social Security   (Peru)

^d HOSPITAL NACIONAL EDGARDO REBAGLIATI MARTINS   (Peru)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f City of Hope   (United States)

Author keywords

Factor IX; Mutagens; Mutations; Race

Indexed keywords

BLOOD CLOTTING FACTOR 9; MUTAGENIC AGENT;

AMERICAN INDIAN; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; ETHNIC GROUP; GENE DELETION; GENE INSERTION; GENE MUTATION; HEMOPHILIA B; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PERU; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0031957550     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1998)11:5<372::AID-HUMU4>3.0.CO;2-M     Document Type: Article

References (34)

1. Bottema CDK, Ketterling RP, Yoon H, Sommer SS (1990) The pattern of factor IX germline mutation m Asians is similar to that of Caucasians. Am J Hum Genet 47:835-841.
2. Bottema CDK, Ketterling RP, Ii S, Yoon H, Phillips JA, III, Sommer SS (1991a) Missense mutations and evolutionary conservation of ammo acids: Evidence that many of the amino acids in factor IX function as "spacer" elements. Am J Hum Genet 49:820-838.
3. Bottema CDK, Bottema MJ, Ketterling RP, Yoon H, Janco RL, Phillips JA, III, Sommer SS (1991b) Why does the human factor IX gene have a G + C content of 40%? Am J Hum Genet 49:839-850.
4. Bottema CDK, Ketterling RP, Vielhaber E, Yoon H, Gostout B, Jacobson DP, Shapiro A, Sommer SS (1993) The pattern of spontaneous germline mutation: Relative rates of mutation at or near CpG dinucleotides in the factor IX gene. Hum Genet 91:496-503.
5. Brash D, Rudolph J, Simon J, Lin A, McKenna G, Baden H, Halperin A, Ponten J (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88 10124-10128.
6. Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa Nature 350 429-431.
7. Camerino G, Grzeschik KH, Jaye M, DeLaSalle H, Tolstoshev P, Lecocq JP, Heilig R, Mandel JL (1984) Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus). Proc Natl Acad Sci USA 81:498-502.
8. Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H (1990) Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 5:1603-1610.
9. Eyster ME, Lewis JH, Shapiro SS, Gill F, Kajani M, Prager D, Djerassi I, Rice S, Lusch C, Keller A (1980) The Pennsylvania hemophilia program 1973-1978. Am J Hematol 9:277-286.
10. Gostout B, Vielhaber E, Ketterling RP, Yoon H, Bottema CDK, Kasper CK, Koerper M, Sommer SS (1993) Germline mutations in the factor IX gene: A comparison of the pattern in Caucasians and non-Caucasians. Hum Molec Genet 2: 293-298.
11. Green PM, Montandon AJ, Bentley DR, Ljung R, Nilsson IM, Giannelli F (1990) The incidence and distribution of CpG→TpG transitions in the coagulation factor IX gene. Nucleic Acids Res 18:3227-3231.
12. Gustafson S, Proper JA, Bowie EJW, Sommer SS (1987) Parameters affecting the yield of DNA from human blood. Anal Biochem 165:294-299.
13. Haldane JBS (1935) The rate of spontaneous mutation of a human gene J Genet 31:317-326.
14. Hedner U, Davie EW (1989) Introduction to hemostasis and the vitamin K-dependent coagulation factor. In Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease New York: McGraw-Hill, pp 2107-2134.
15. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428.
16. Jacobson DP, Schmeling P, Sommer SS (1993) Characterization of the patterns of polymorphism in a "cryptic repeat" reveals a novel type of hypervariable sequence. Am J Hum Genet 53:443-450.
17. Ketterling RP, Bottema CDK, Phillips JP, III, Sommer SS (1991) Evidence that descendants of three founders comprise about 25% of hemophilia B in the United States. Genomics 10:1093-1096.
18. Koeberl DD, Bottema CDK, Buerstedde J, Sommer SS (1989) Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG. Am J Hum Genet 45:448-457
19. Koeberl DD, Bottema CDK, Ketterling RP, Bridge PJ, Lillicrap DP, Sommer SS (1990) Mutations causing hemophilia B: Direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in the human gene. Am J Hum Genet 47:202-217.
20. Mehta CR, Patel NR (1983) A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 78:427-134.
21. Sarkar G, Paynton C, Sommer SS (1991) Segments containing alternating purine and pyrimidine dinucleotides: Patterns of polymorphism in humans and prevalence throughout phylogeny. Nucleic Acids Res 19:631-636.
22. Sommer SS, Sarkar G, Koeberl DD, Bottema CDK, Buerstedde J, Schowalter DB, Cassady JD (1990a) Direct sequencing with the aid of phage promoters. In Innis MA, Gelfand DH, Sninsky JJ, White TJ, (eds): PCR Protocols. A Guide to Methods and Applications. New York. Academic Press, pp 197-205.
23. Sommer SS (1990b) Mutagen test. Nature 346:22-23.
24. Sommer SS (1992) Assessing the underlying pattern of human germline mutations: Lessons from the factor IX gene. FASEB J 6:2767-2774
25. Sommer SS, Tillotson VL, Vielhaber EL, Ketterling RP, Dutton CM (1994) "Cryptic" dinucleotide polymorphism in the 3′ region of the factor IX gene shows substantial variation among different populations. Hum Genet 93:357-358.
26. Sommer SS (1995) Recent human germ-line mutation: inferences from patients with hemophilia B. TIG 11:141-147.
27. Stoflet ES, Koeberl DD, Sarkar G, Sommer SS (1988) Genomic amplification with transcript sequencing Science 239:491-494.
28. Suzuki DT, Griffiths AJF, Miller JH, Lewontin RC (1986) An introduction to genetic analysis: Mechanisms of genetic change. I. In: Gene Mutation. New York: Freeman, pp 333-53.
29. Takeshima Y, Seyama T, Bennett WP, Akyama M, Tokuoka S, Inai K, Mabuchi K, Land CE, Harris CC (1993) p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342:1520-1521.
30. Thorland EC, Weinshenker BG, Liu J, Ketterling RP, Vielhaber EL, Kasper CK, Ambriz R, Paredes R, Sommer SS (1995) Molecular epidemiology of factor IX germline mutations in Mexican Hispanics: Pattern of mutation and potential founder effects. Thromb Haemost 74:1416-1422.
31. Vogel F, Rathenberg R (1975) Spontaneous mutation in man. Adv Hum Genet 5:223-318.
32. Winship PR, Anson DS, Rizza CR, Brownlee GG (1984) Carrier detection in haemophilia B using two further intragenic restricition length polymorphisms. Nucleic Acids Res 12:8861-8872.
33. Winship PR, Rees DJG, Alkan M (1989) Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers. Lancet i:631-634.
34. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K (1985) Nucleotide sequence of the gene for human factor IX (anti-hemophilic factor B). Biochemistry 24:3736-3750.